Table 7 shows that IMP3 could be used to predict mortality, local recurrence, and distant metastasis in SCC on top of IP at cut‐off levels ≥ 55, ≥31, and ≥49, respectively, with 100% sensitivity and specificity. The gene discussed is IMP3; the disease is incontinentia pigmenti.